(Q34626926)

3 August 2017

title

Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin (English)

1 reference

3 August 2017

0 references

0 references

1 reference

1 reference

Zhen-Yu He

1

1 reference

3 August 2017

Chuan-Bing Shi

2

1 reference

3 August 2017

Hao Wen

3

1 reference

3 August 2017

Fang-Long Li

4

1 reference

3 August 2017

Bao-Lin Wang

5

1 reference

3 August 2017

Jie Wang

6

1 reference

3 August 2017

publication date

1 March 2011

1 reference

3 August 2017

1 reference

3 August 2017

volume

29

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

208-213

1 reference

The effect of provider case volume on cancer mortality: systematic review and meta-analysis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

Multi-targeted therapy by curcumin: how spicy is it?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

Cachexia in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

New mechanisms and therapeutic potential of curcumin for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

Assays to measure p53-dependent and -independent apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2010.550592

10.3109/07357907.2010.550592

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference